BIOMAT Database Logo BIOMAT Database Logo

Pancytopenia following low-dose methotrexate therapy. 1988

E A Abel, and E M Farber

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D010198 Pancytopenia Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets. Pancytopenias
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

E A Abel, and E M Farber
Pancytopenia following low-dose oral methotrexate therapy for psoriasis.
June 1988, JAMA,
E A Abel, and E M Farber
Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
July 2008, Human & experimental toxicology,
E A Abel, and E M Farber
Low-dose methotrexate-induced pancytopenia.
January 2007, Clinical rheumatology,
E A Abel, and E M Farber
Pancytopenia associated with low dose methotrexate therapy. A regional survey.
July 1993, The Journal of rheumatology,
E A Abel, and E M Farber
[Pancytopenia during low-dose oral methotrexate therapy of psoriatic arthritis].
August 1989, Deutsche medizinische Wochenschrift (1946),
E A Abel, and E M Farber
Low-Dose Methotrexate Toxicity Presenting as Pancytopenia.
December 2022, Cureus,
E A Abel, and E M Farber
Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
December 2001, The Annals of pharmacotherapy,
E A Abel, and E M Farber
Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis.
August 1988, Australian and New Zealand journal of medicine,
E A Abel, and E M Farber
Pancytopenia after Low-Dose Methotrexate Therapy in Two Hemodialysis Patients with Rheumatoid Arthritis.
February 2022, The American journal of the medical sciences,
E A Abel, and E M Farber
Disseminated histoplasmosis following prolonged low-dose methotrexate therapy.
January 2000, American journal of hematology,
Copied contents to your clipboard!